Clinical Trial Update: The Benefits of Long-read High-throughput Genomic Sequencing for the Causal Diagnosis of Cerebellar Ataxias [NA]

View source ↗

Summary

The document discusses how long-read high-throughput genomic sequencing can improve causal diagnosis of cerebellar ataxias in a clinical trial setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebellar Ataxias

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Cerebellar Ataxias | NA | Status: RECRUITING